Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BTCY Biotricity > Detailed Quotes

BTCY Biotricity

0.970
+0.057+6.24%
Close 10/06 16:00 ET
1.040
+0.070+7.22%
Post Mkt Price 10/06 16:59 ET
High
1.040
Open
0.913
Turnover
56.14K
Low
0.913
Pre Close
0.913
Volume
57.31K
Market Cap
50.34M
P/E(TTM)
Loss
52wk High
5.300
Shares
51.90M
P/E(Static)
Loss
52wk Low
0.750
Float Cap
38.93M
Bid/Ask %
-20.00%
Historical High
5.300
Shs Float
40.14M
Volume Ratio
1.26
Historical Low
0.750
Dividend TTM
--
Div Yield TTM
--
P/B
-7.70
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.14%
Amplitude
13.90%
Avg Price
0.979
Lot Size
1
Float Cap
38.93M
Bid/Ask %
-20.00%
Historical High
5.300
Shs Float
40.14M
Volume Ratio
1.26
Historical Low
0.750
Dividend TTM
--
P/B
-7.70
Dividend LFY
--
Turnover Ratio
0.14%
Amplitude
13.90%
Avg Price
0.979
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It is also involved in delivering remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology is comprised of monitoring device and software components, which are made available to the market to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.
CEO: Mr. Waqaas Al-Siddiq
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...